Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / American depositary shares, each representing one equity share
-
Shares outstanding
-
834,731,296
-
Number of holders
-
239
-
Total 13F shares, excl. options
-
107,490,178
-
Shares change
-
-649,402
-
Total reported value, excl. options
-
$1,615,554,376
-
Value change
-
-$2,437,828
-
Number of buys
-
136
-
Number of sells
-
89
-
Price
-
$15.03
Institutional Holders of DR REDDYS LABORATORIES LTD - American depositary shares, each representing one equity share (RDY) as of Q2 2025
As of 30 Jun 2025 DR REDDYS LABORATORIES LTD - American depositary shares, each representing one equity share (RDY) had 274 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 107,490,178 shares of stock of the company.
Largest 10 holders included Robeco Institutional Asset Management B.V., BlackRock, Inc., Royal Bank of Canada, RENAISSANCE TECHNOLOGIES LLC, Aikya Investment Management Ltd, JPMORGAN CHASE & CO, DIMENSIONAL FUND ADVISORS LP, VANGUARD GROUP INC, MORGAN STANLEY, and STATE STREET CORP.
This table shows 274 institutional shareholders of the security as of 30 Jun 2025.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.